TP53 and neoplasm: Furthermore, other sites examined, like VEGFA (which enhances vascularisation in tumours) and RAG1 and FANCF (which contribute to genomic instability), have not been previously associated with short-term proliferative advantages in vitro, unlike p53 or p21 knockouts.